The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.
Chronic inflammation and coronary microvascular dysfunction in patients without risk factors for coronary artery disease
Abstract
AIMS: To demonstrate that exposure to chronic inflammation results in coronary microvascular dysfunction (CMD). METHODS AND RESULTS: Using positron emission tomography, resting and hyperaemic (adenosine, 140 microg/kg/min) myocardial blood flow (MBF) was measured in 25 patients with systemic lupus erythematosus (SLE) or rheumatoid arthritis (RA). Coronary flow reserve (CFR) was calculated as adenosine/resting MBF. Patients had normal or minimally diseased (i.e. <or=20% luminal diameter) coronary arteries at angiography and no cardiovascular risk factors. Twenty five age- and gender-matched healthy volunteers served as controls. Resting MBF was similar in patients and controls (1.25 +/- 0.27 vs. 1.15 +/- 0.24 mL/min/g; P = 0.15) while patients had lower hyperaemic MBF (2.94 +/- 0.83 vs. 4.11 +/- 0.84 mL/min/g; P < 0.001) and CFR (2.44 +/- 0.78 vs. 3.81 +/- 1.07; P < 0.001). CFR was inversely related to disease duration (r = -0.65; P < 0.001) and SLE disease activity (r = -0.69; P = 0.01). Seven patients showed ischaemic electrocardiographic changes during adenosine. They had longer disease duration (21 +/- 7 vs. 14 +/- 5 years; P = 0.03) and lower CFR (1.76 +/- 0.81 vs. 2.49 +/- 0.54; P = 0.006) when compared with patients without changes. CONCLUSION: A reduced CFR in the absence of significant coronary disease is suggestive of CMD. We speculate that this is the consequence of prolonged systemic inflammation, which may precede and contribute to premature coronary artery disease in these patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Coronary microvascular dysfunction is an early marker of accelerated coronary atherosclerosis and may contribute to the increased cardiovascular morbidity and mortality in these patients.189”
From European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) (2012) · cites this paper as [189]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Arnett, F. C., Edworthy, S. M., Bloch, D. A., McShane, D. J., Fries, J. F., Cooper, N. S., Healey, L. A., Kaplan, S. R., Liang, M. H., Luthra, H. S., et al. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310302 · Cited by 19,753
Prediction of Creatinine Clearance from Serum Creatinine
Cockcroft, D. W., & Gault, H. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000180580 · Cited by 15,291
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
Inflammation and Atherosclerosis
Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724
Derivation of the sledai. A disease activity index for lupus patients
Bombardier, C., Gladman, D. D., Urowitz, M. B., Caron, D., Chang, C. H., Austin, A., Bell, A., Bloch, D. A., Corey, P. N., Decker, J. L., et al. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780350606 · Cited by 4,570
Analysis of probability as an aid in the clinical diagnosis of coronary artery disease.
Diamond, G. A., & Forrester, J. S. (1979) · New England Journal of Medicine · doi:10.1056/nejm197906143002402 · Cited by 2,664
Manzi, S., Meilahn, E. N., Rairie, J. E., Conte, C. G., Medsger, T. A., Jansen-McWilliams, L., D’Agostino, R. B., & Kuller, L. H. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009122 · Cited by 1,831
Coronary Microvascular Dysfunction
Camici, P. G., & Crea, F. (2007) · New England Journal of Medicine · doi:10.1056/nejmra061889 · Cited by 1,680
Self-citationPrevalence and Correlates of Accelerated Atherosclerosis in Systemic Lupus Erythematosus
Roman, M. J., Shanker, B., Davis, A., Lockshin, M. D., Sammaritano, L. R., Simantov, R., Crow, M. K., Schwartz, J. E., Paget, S. A., Devereux, R. B., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035471 · Cited by 1,422
Research works printed but not linked: 4
- Kaufmann, 2005, Journal of Nuclear Medicine, 46, 75
- 2008, 198, 332
- 1989, American Journal of Physiology -- Legacy Content, 257, E309
- 2000, 152, 127
Cited by
Sorted by citations
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490
European guidelines on cardiovascular disease prevention in clinical practice: executive summary
Graham, I., Atar, D., Borch‐Johnsen, K., Boysen, G., Burell, G. K., Cífková, R., Dallongeville, J., Backer, G. D., Ebrahim, S. B. J., Gjelsvik, B., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm316 · Cited by 3,865
2024 ESC Guidelines for the management of chronic coronary syndromes
Vrints, C. J., Andreotti, F., Koskinas, K. C., Rosselló, X., Adamo, M., Ainslie, J., BANNING, A. P., Budaj, A., Buechel, R. R., Chiariello, G. A., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae177 · Cited by 3,521
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Authors/Task Force Members, Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M. T., Corrà, U., Cosyns, B., et al. (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487316653709 · Cited by 1,435
Kunadian, V., Chieffo, A., Camici, P. G., Berry, C., Escaned, J., Maas, A. H. E. M., Prescott, E., Karam, N., Appelman, Y., Fraccaro, C., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa503 · Cited by 867
Self-citationIschemia and No Obstructive Coronary Artery Disease (INOCA)
Merz, C. N. B., Pepine, C. J., Walsh, M. N., Fleg, J. L., Camici, P. G., Chilian, W. M., Clayton, J. A., Cooper, L. S., Crea, F., Carli, M. F. D., et al. (2017) · Circulation · doi:10.1161/circulationaha.116.024534 · Cited by 752
Self-citationMehta, N. N., Azfar, R. S., Shin, D. B., Neimann, A. L., Troxel, A. B., & Gelfand, J. M. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehp567 · Cited by 706
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Perk, J., Backer, G. D., Gohlke, H., Graham, I. M., Reiner, Ž., Verschuren, W. M. M., Albus, C., Benlian, P., Boysen, G., Cífková, R., et al. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.05.007 · Cited by 702
Endothelial Dysfunction in Chronic Inflammatory Diseases
Steyers, C. M., & Miller, F. J. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150711324 · Cited by 498
Mason, J. C., & Libby, P. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehu403 · Cited by 420
Self-citationCoronary Microvascular Dysfunction
Vancheri, F., Longo, G., Vancheri, S., & Henein, M. Y. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9092880 · Cited by 354
European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012)
Perk, J., Backer, G. D., Gohlke, H., Graham, I. M., Reiner, Ž., Verschuren, W. M. M., Albus, C., Benlian, P., Boysen, G., Cífková, R., et al. (2012) · International Journal of Behavioral Medicine · doi:10.1007/s12529-012-9242-5 · Cited by 319
Cardiovascular disease in autoimmune rheumatic diseases
Hollan, I., Meroni, P. L., Ahearn, J. M., Tervaert, J. W. C., Curran, S., Goodyear, C. S., Hestad, K. A., Kahaleh, B., Riggio, M. P., Shields, K. J., et al. (2013) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.03.013 · Cited by 278
Kunadian, V., Chieffo, A., Camici, P. G., Berry, C., Escaned, J., Maas, A. H. E. M., Prescott, E., Karam, N., Appelman, Y., Fraccaro, C., et al. (2021) · EuroIntervention · doi:10.4244/eijy20m07_01 · Cited by 273
Self-citationAccelerated atherosclerosis in patients with SLE—mechanisms and management
Skaggs, B. J., Hahn, B. H., & McMahon, M. A. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2012.14 · Cited by 253
Authors/Task Force Members: Joep Perk (Chairperson) (Sweden)*, G. D. B. (. (2012) · European Journal of Preventive Cardiology · doi:10.1177/2047487312450228 · Cited by 863
Pries, A. R., Badimón, L., Bugiardini, R., Camici, P. G., Dorobanţu, M., Duncker, D. J., Escaned, J., Koller, Á., Piek, J. J., & de Wit, C. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv100 · Cited by 228
Self-citationCoronary microvascular dysfunction in hypertrophy and heart failure
Camici, P. G., Tschöpe, C., Carli, M. F. D., Rimoldi, O. E., & Linthout, S. V. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa023 · Cited by 217
Self-citationQuantitative Assessment of Coronary Microvascular Function
Fehér, A., & Sinusas, A. J. (2017) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.117.006427 · Cited by 191
Treatment of coronary microvascular dysfunction
Merz, C. N. B., Pepine, C. J., Shimokawa, H., & Berry, C. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa006 · Cited by 190
ISHIMORI, M. L., Martin, R., Berman, D. S., Goykhman, P., Shaw, L. J., SHUFELT, C. L., Slomka, P. J., Thomson, L., Schapira, J. N., Yang, Y., et al. (2011) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2010.09.019 · Cited by 185
Microvascular endothelial dysfunction in rheumatoid arthritis
Bordy, R., Totoson, P., Prati, C., Marie, C., Wendling, D., & Demougeot, C. (2018) · Nature Reviews Rheumatology · doi:10.1038/s41584-018-0022-8 · Cited by 189
Mayoral, A. R., Rimoldi, O. E., Camici, P. G., & Kaski, J. C. (2013) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2012.12.011 · Cited by 182
Self-citationCoronary Microvascular Dysfunction and Cardiovascular Risk in Obese Patients
Bajaj, N. S., Osborne, M. T., Gupta, A., Tavakkoli, A., Bravo, P. E., Vita, T. S., Bibbo, C. F., Hainer, J. M., Dorbala, S., Blankstein, R., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.05.049 · Cited by 179
Pugliese, N. R., Pellicori, P., Filidei, F., Biase, N. D., Maffia, P., Guzik, T. J., Masi, S., Taddei, S., & Cleland, J. G. F. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac133 · Cited by 150
Coronary microvascular dysfunction in chronic inflammatory rheumatoid diseases
Faccini, A., Kaski, J. C., & Camici, P. G. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw018 · Cited by 138
Self-citationMechanisms of Premature Atherosclerosis in Rheumatoid Arthritis and Lupus
Kahlenberg, J. M., & Kaplan, M. J. (2012) · Annual Review of Medicine · doi:10.1146/annurev-med-060911-090007 · Cited by 132
Coronary Microvascular Dysfunction, Microvascular Angina, and Management
Loffler, A. I., & Bourque, J. M. (2015) · Current Cardiology Reports · doi:10.1007/s11886-015-0682-9 · Cited by 132
Novel insights into an “old” phenomenon: the no reflow
Durante, A., & Camici, P. G. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.03.359 · Cited by 126
Self-citationSex differences in non-obstructive coronary artery disease
Waheed, N., Elias‐Smale, S. E., Malas, W., Maas, A. H. E. M., Sedlak, T., Tremmel, J. A., & Mehta, P. K. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa001 · Cited by 126
Coronary Microvascular Dysfunction
Godo, S., Suda, A., TAKAHASHI, J. C., Yasuda, S., & Shimokawa, H. (2021) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.121.316025 · Cited by 121
Chen, C., Wei, J., AlBadri, A., Zarrini, P., & Merz, C. N. B. (2016) · Circulation Journal · doi:10.1253/circj.cj-16-1002 · Cited by 115
Non-invasive anatomic and functional imaging of vascular inflammation and unstable plaque
Camici, P. G., Rimoldi, O. E., Gaemperli, O., & Libby, P. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs067 · Cited by 104
Self-citationThornton, C. C., Alrashed, F. A., Calay, D., Birdsey, G. M., Bauer, A., Mylroie, H., Morley, B. J., RANDI, A. M., Haskard, D. O., Boyle, J. J., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-206305 · Cited by 94
Self-citationVaccarino, V., Khan, D., Votaw, J. R., Faber, T. L., Veledar, E., Jones, D. P., Goldberg, J. H., Raggi, P., Quyyumi, A. A., & Bremner, J. D. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.09.074 · Cited by 91
Gender in cardiovascular medicine: chest pain and coronary artery disease
Mehta, P. K., Bess, C., Elias‐Smale, S. E., Vaccarino, V., Quyyumi, A. A., Pepine, C. J., & Merz, C. N. B. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz784 · Cited by 88
Durante, A., & Bronzato, S. (2015) · Journal of Clinical Medicine Research · doi:10.14740/jocmr2122w · Cited by 83
Inflammation and Coronary Microvascular Dysfunction in Autoimmune Rheumatic Diseases
Zanatta, E., Colombo, C., D’Amico, G., d’Humières, T., Lin, C. D., & Tona, F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225563 · Cited by 82
Prabakaran, S., Schwartz, A. M., & Lundberg, G. P. (2021) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188211013917 · Cited by 83
Wehbe, Z., Hammoud, S. H., Soudani, N., Zaraket, H., EL‐Yazbi, A. F., & Eid, A. H. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00836 · Cited by 71
Novel Insights in Systemic Lupus Erythematosus and Atherosclerosis
Teixeira, V. S., & Tam, L. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2017.00262 · Cited by 75
Definition and epidemiology of coronary microvascular disease
Bradley, C., & Berry, C. (2022) · Journal of Nuclear Cardiology · doi:10.1007/s12350-022-02974-x · Cited by 69
Winau, L., Baydés, R. H., Braner, A., Drott, U., Burkhardt, H., Sangle, S. R., D’Cruz, D. P., Carr‐White, G., Marber, M. S., Schnoes, K., et al. (2018) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-213661 · Cited by 69
The interplay of inflammation and cardiovascular disease in systemic lupus erythematosus
Kahlenberg, J. M., & Kaplan, M. J. (2010) · Arthritis Research & Therapy · doi:10.1186/ar3264 · Cited by 67
Ntusi, N., Francis, J. M., Sever, E., Liu, A., Piechnik, S. K., Ferreira, V. M., Matthews, P. M., Robson, M. D., Wordsworth, P. B., Neubauer, S., et al. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.06.099 · Cited by 67
Wigren, M., Nilsson, J., & Kaplan, M. J. (2015) · Journal of Internal Medicine · doi:10.1111/joim.12357 · Cited by 64
Piaserico, S., Osto, E., Famoso, G., Zanetti, I., Gregori, D., Poretto, A., Iliceto, S., Peserico, A., & Tona, F. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.05.036 · Cited by 62
Coronary microvascular disease: current concepts of pathophysiology, diagnosis and management
Sinha, A., Rahman, H., & Perera, D. (2020) · Cardiovascular Endocrinology & Metabolism · doi:10.1097/xce.0000000000000223 · Cited by 56
Weber, B., Stevens, E. F., Perez-Chada, L. M., Brown, J. M., Divakaran, S., Bay, C. P., Bibbo, C. F., Hainer, J. M., Dorbala, S., Blankstein, R., et al. (2021) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2020.12.031 · Cited by 56
Novel Imaging Approaches to Cardiac Manifestations of Systemic Inflammatory Diseases
Weber, B., Paik, J. J., Aghayev, A., Klein, A. L., Mavrogeni, S. I., Yu, P. B., & Mukherjee, M. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.09.819 · Cited by 54
Role of Inflammation in Coronary Epicardial and Microvascular Dysfunction
Godo, S., TAKAHASHI, J. C., Yasuda, S., & Shimokawa, H. (2021) · European Cardiology Review · doi:10.15420/ecr.2020.47 · Cited by 54
Schindler, T. H., Cadenas, J., Facta, A. D., Li, Y., Olschewski, M., Sayre, J. W., Goldin, J. G., & Schelbert, H. R. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp482 · Cited by 53
Myocardial Microvascular Dysfunction in Rheumatoid Arthritis
Amigues, I., Russo, C. A., Giles, J. T., Tuğcu, A., Weinberg, R. L., Bokhari, S., & Bathon, J. M. (2019) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.117.007495 · Cited by 53
Impact of Acute and Chronic Psychosocial Stress on Vascular Inflammation
Hinterdobler, J., Schunkert, H., Kessler, T., & Sager, H. B. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0153 · Cited by 56
Myocardial Dysfunction and Heart Failure in Rheumatoid Arthritis
Park, E., Griffin, J. M., & Bathon, J. M. (2021) · Arthritis & Rheumatology · doi:10.1002/art.41979 · Cited by 51
Coronary Microvascular Dysfunction in Systemic Lupus Erythematosus
Weber, B., Stevens, E. F., Barrett, L., Bay, C. P., Sinnette, C., Brown, J. M., Divakaran, S., Bibbo, C. F., Hainer, J. M., Dorbala, S., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.018555 · Cited by 50
Smoking, alcohol and opioids effect on coronary microcirculation: an update overview
Jalali, Z., Khademalhosseini, M., Soltani, N., & Nadimi, A. E. (2021) · BMC Cardiovascular Disorders · doi:10.1186/s12872-021-01990-y · Cited by 53
Coronary flow reserve in systemic rheumatic diseases: a systematic review and meta-analysis
Erre, G. L., Buscetta, G., Paliogiannis, P., Mangoni, A. A., Carru, C., Passiu, G., & Zinellu, A. (2018) · Rheumatology International · doi:10.1007/s00296-018-4039-8 · Cited by 48
Ong, P., Athanasiadis, A., Hill, S., Schäufele, T. G., Mahrholdt, H., & Sechtem, U. P. (2014) · Clinical Cardiology · doi:10.1002/clc.22282 · Cited by 46
Santos, M. J., Pedro, L. M., Canhão, H. M., Fernandes, J. F. E., da Silva, J. C., Fonseca, J. E., & Saldanha, C. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.08.026 · Cited by 45
Renal Function and Coronary Microvascular Dysfunction in Women with Symptoms/Signs of Ischemia
Mohandas, R., Segal, M. S., Huo, T., Handberg, E. M., Petersen, J. W., Johnson, B. D., Sopko, G. S., Merz, C. N. B., & Pepine, C. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125374 · Cited by 45
Inflammation, Coronary Flow Reserve, and Microvascular Dysfunction
Taqueti, V. R., & Ridker, P. M. (2013) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2013.02.005 · Cited by 43
Faccini, A., Agricola, E., Oppizzi, M., Margonato, A., Galderisi, M., Sabbadini, M. G., Franchini, S., & Camici, P. G. (2015) · Circulation Journal · doi:10.1253/circj.cj-14-1114 · Cited by 39
Self-citationLiao, K. P., Huang, J., He, Z., Cremone, G., Lam, E., Hainer, J. M., Morgan, V., Bibbo, C. F., & Carli, M. F. D. (2019) · Arthritis Care & Research · doi:10.1002/acr.24108 · Cited by 38
Ischaemic heart disease in patients with cancer
Ameri, P., Bertero, E., Lombardi, M., Porto, I., Canepa, M., Nohria, A., Vergallo, R., Lyon, A. R., & López‐Fernández, T. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae047 · Cited by 39
Accelerated atherosclerosis in patients with chronic inflammatory rheumatologic conditions
Hong, J., Maron, D. J., Shirai, T., & Weyand, C. M. (2015) · International Journal of Clinical Rheumatology · doi:10.2217/ijr.15.33 · Cited by 37
Pasqualetto, M. C., Tuttolomondo, D., Cutruzzolà, A., Niccoli, G., Dey, D., Greco, A., Martini, C., Irace, C., Rigo, F., & Gaibazzi, N. (2021) · International Journal of Cardiology · doi:10.1016/j.ijcard.2021.05.040 · Cited by 37
Pathogenesis and Treatment of Atherosclerosis in Lupus
McMahon, M. A., & Skaggs, B. J. (2014) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2014.04.003 · Cited by 35
Coronary microvascular dysfunction: Considerations for diagnosis and treatment
Tjoe, B., Barsky, L. L., Wei, J., Samuels, B. A., Azarbal, B., Merz, C. N. B., & SHUFELT, C. L. (2021) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.88a.20140 · Cited by 36
Kakuta, K., Dohi, K., Sato, Y., Yamanaka, T., Kawamura, M., Ogura, T., Nakamori, S., Fujimoto, N., Fujii, E., Yamada, N., et al. (2015) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2015.09.001 · Cited by 34
Wang, X., Han, Y., Zhang, S., Cui, N., Liu, Z., Huang, Z., Li, C., & Zheng, F. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12929 · Cited by 34
Safdar, B., Guo, X., Johnson, C. E., D’Onofrio, G., Dziura, J., Sinusas, A. J., Testani, J. M., Rao, V., & Désir, G. V. (2019) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.12.061 · Cited by 33
Gaibazzi, N., Picano, E., Suma, S., Garibaldi, S., Porter, T. R., Botti, A., Tuttolomondo, D., Tedeschi, A., & Lorenzoni, V. (2020) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2020.01.007 · Cited by 35
Cardiovascular disease in systemic lupus erythematosus
McMahon, M. A., Seto, R., & Skaggs, B. J. (2021) · Rheumatology and Immunology Research · doi:10.2478/rir-2021-0022 · Cited by 32
Gianturco, L., Bodini, B. D., Atzeni, F., Colombo, C., Stella, D., Sarzi‐Puttini, P., Drago, L., Galaverna, S., & Turiel, M. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.03.044 · Cited by 32
Long-term prognostic value of coronary flow reserve in psoriasis patients
Piaserico, S., Osto, E., Famoso, G., Montisci, R., Michieli, L. D., Zanetti, I., Iliceto, S., & Tona, F. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.08.009 · Cited by 32
Grundtman, C., Hollan, I., Førre, Ø., Saatvedt, K. J., Mikkelsen, K., & Lundberg, I. E. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27264 · Cited by 31
Akhiyat, N., Lasho, T., Ganji, M., Toya, T., Shi, C., Chen, X., Braggio, E., Ahmad, A., Corban, M., Stewart, K., et al. (2023) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.122.318928 · Cited by 31
Endothelial Dysfunction in Systemic Lupus Erythematosus: Evaluation with 13N-Ammonia PET
Alexánderson, E., Ochoa, J. M., Calleja, R., Juárez-Rojas, J. G., Prior, J. O., Jácome, R., Romero, E., Meave, A., & Posadas‐Romero, C. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.078212 · Cited by 31
Chen, S. K., Barbhaiya, M., Fischer, M. A., Guan, H., Yoshida, K., Feldman, C. H., Costenbader, K. H., & Everett, B. M. (2019) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2019.06.005 · Cited by 29
Mahmoud, I., Dykun, I., Kärner, L., Hendricks, S., Totzeck, M., Al‐Rashid, F., Rassaf, T., & Mahabadi, A. A. (2021) · International Journal of Obesity · doi:10.1038/s41366-021-00875-6 · Cited by 29
Yaşar, E., & Bayramoğlu, A. (2022) · Angiology · doi:10.1177/00033197221087777 · Cited by 29
Fehér, A., Boutagy, N. E., Oikonomou, E. K., Liu, Y.-H., Miller, E. J., Sinusas, A. J., & Hinchcliff, M. (2021) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.120.012208 · Cited by 28
Under crossfire: thromboembolic risk in systemic lupus erythematosus
Ramirez, G. A., Efthymiou, M., Isenberg, D. A., & Cohen, H. (2018) · Rheumatology · doi:10.1093/rheumatology/key307 · Cited by 29
Imaging Risk in Multisystem Inflammatory Diseases
Ikonomidis, I., Makavos, G., Katsimbri, P., Boumpas, D. T., Parissis, J., & Iliodromitis, E. K. (2019) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2018.06.033 · Cited by 25
Carbone, A., D’Andrea, A., Sperlongano, S., Tagliamonte, E., Mandoli, G. E., Santoro, C., Evola, V., Bandera, F., Morrone, D., Malagoli, A., et al. (2021) · Echocardiography · doi:10.1111/echo.15059 · Cited by 25
Coronary Microvascular Dysfunction in HIV: A Review
Rethy, L. B., Feinstein, M. J., Sinha, A., Achenbach, C. J., & Shah, S. J. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.014018 · Cited by 25
Angiogenic CD34 Stem Cell Therapy in Coronary Microvascular Repair—A Systematic Review
Rai, B., Shukla, J., Henry, T. D., & Quesada, O. (2021) · Cells · doi:10.3390/cells10051137 · Cited by 24
Coronary Microvascular Dysfunction in Asymptomatic Patients with Severe Psoriasis
Piaserico, S., Papadavid, E., Cecere, A., Orlando, G., Theodoropoulos, K., Katsimbri, P., Makavos, G., Rafouli-Stergiou, P., Iliceto, S., Alaibac, M., et al. (2023) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2023.02.037 · Cited by 24
Relation of Albuminuria to Coronary Microvascular Function in Patients With Chronic Kidney Disease
Imamura, S., Hirata, K., Orii, M., Shimamura, K., Shiono, Y., Ishibashi, K., Tanimoto, T., Yamano, T., Ino, Y., Kitabata, H., et al. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.11.026 · Cited by 25
Cardiovascular complications of rheumatoid arthritis
Park, E., & Bathon, J. M. (2024) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000001004 · Cited by 23
Gijsberts, C. M., Gohar, A., Ellenbroek, G. H. J. M., Hoefer, I. E., de Kleijn, D. P. V., Asselbergs, F. W., Nathoe, H. M., Agostoni, P., Rittersma, S. Z. H., Pasterkamp, G., et al. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.02.002 · Cited by 23
Cytoprotective pathways in the vascular endothelium. Do they represent a viable therapeutic target?
Mason, J. C. (2016) · Vascular Pharmacology · doi:10.1016/j.vph.2016.08.002 · Cited by 22
Self-citationCoronary Microvascular Dysfunction in Patients With Systemic Lupus Erythematosus and Chest Pain
Manchanda, A. S., Kwan, A. C., Ishimori, M., Thomson, L. E. J., Li, D., Berman, D. S., Merz, C. N. B., Jefferies, C., & Wei, J. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.867155 · Cited by 21
Shah, S. A., Reagan, C. E., Bresticker, J. E., Wolpe, A. G., Good, M. E., Macal, E. H., Billcheck, H. O., Bradley, L. A., French, B. A., Isakson, B. E., et al. (2023) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2022.11.005 · Cited by 21
Quantification of intramyocardial blood volume with 99mTc-RBC SPECT-CT imaging: A preclinical study
Mohy‐ud‐Din, H., Boutagy, N. E., Stendahl, J. C., Zhuang, Z. W., Sinusas, A. J., & Liu, C. (2017) · Journal of Nuclear Cardiology · doi:10.1007/s12350-017-0970-4 · Cited by 20
Coronary Microvascular Dysfunction and the Role of Noninvasive Cardiovascular Imaging
Ayub, M. T., & Kalra, D. K. (2020) · Diagnostics · doi:10.3390/diagnostics10090679 · Cited by 21
Ong, P., Carro, A., Athanasiadis, A., Borgulya, G., Schäufele, T. G., Ratge, D., Gaze, D. C., Sechtem, U. P., & Kaski, J. C. (2014) · Coronary Artery Disease · doi:10.1097/mca.0000000000000181 · Cited by 21
Self-citationFehér, A., Boutagy, N. E., Oikonomou, E. K., Thorn, S., Liu, Y.-H., Miller, E. J., Sinusas, A. J., & Hinchcliff, M. (2021) · The Journal of Rheumatology · doi:10.3899/jrheum.210040 · Cited by 20
Erhayiem, B., Pavitt, S. H., Baxter, P. D., Andrews, J., Greenwood, J. P., Buch, M. H., & Plein, S. (2014) · Trials · doi:10.1186/1745-6215-15-436 · Cited by 19
Metadata
- Authors
- Recio-Mayoral, A., Mason, J. C., Kaski, J. C., Rubens, M. B., Harari, O. A., & Camici, P. G.
- Affiliations
- Imperial College London (GB)
- St George's, University of London (GB)
- Royal Brompton Hospital (GB)
- Corresponding author
- Camici, P. G.
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-06-05
- Volume
- 30
- Issue
- 15
- Pages
- 1837-1843
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- OpenAlex
- W2021794274
- Cited by
- 235
- References
- 50
- Citations by year
- 2026: 9 · 2025: 12 · 2024: 15 · 2023: 11 · 2022: 14 · 2021: 28 · 2020: 15 · 2019: 14 · 2018: 14 · 2017: 11 · 2016: 13 · 2015: 20 · 2014: 12 · 2013: 11 · 2012: 17
- FWCI
- 8.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Heart Journal (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- Sociedad Española de Cardiología
- Cardiovascular Research Foundation
- National Institute for Health and Care Research
- British Heart Foundation (PG/08001)
- Topics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Cardiac Imaging and Diagnostics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Keywords
- chronic inflammation, coronary microvascular dysfunction, coronary flow reserve, systemic lupus erythematosus, rheumatoid arthritis, myocardial blood flow, disease duration, disease activity, myocardial ischemia, premature coronary artery disease
- MeSH terms
- Adenosine, Adult, Arthritis, Rheumatoid, Coronary Artery Disease, Coronary Circulation, Endothelium, Vascular, Female, Humans, Inflammation, Lupus Erythematosus, Systemic, Male, Microcirculation, Prospective Studies, Vasodilator Agents, Case-Control Studies, Risk Assessment, Positron-Emission Tomography, Fractional Flow Reserve, Myocardial
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
